Treatment of Bell's Palsy at Day 5

Evidence for Timing of Steroid Treatment

The American Academy of Otolaryngology-Head and Neck Surgery guidelines strongly recommend oral corticosteroids only when initiated within 72 hours of symptom onset 3, 4
The recommended regimen is prednisolone 50 mg daily for 10 days or prednisone 60 mg daily for 5 days followed by a 5-day taper, but this is only effective when started within the 72-hour window 1
Clinical trials demonstrating steroid efficacy specifically enrolled patients within 72 hours of symptom onset, with no clear evidence supporting later administration 4
The benefit of treatment after 72 hours is less clear and not supported by high-quality evidence 3, 1

Early corticosteroid treatment aims to reduce inflammation of the facial nerve before permanent damage occurs 4
Studies showing benefit (83% recovery at 3 months with prednisolone vs 63.6% with placebo) specifically enrolled patients within the 72-hour window 4

Focus on eye protection if the patient has impaired eye closure to prevent corneal damage 5, 1
Implement lubricating ophthalmic drops for daytime protection 5
Use ophthalmic ointments for nighttime protection 5
Consider moisture chambers, eye patching/taping, and sunglasses as appropriate 5
Monitor for recovery and consider referral if new or worsening neurologic findings develop 1
Monitor for recovery and consider referral if ocular symptoms develop 1
Monitor for recovery and consider referral if incomplete facial recovery persists 3 months after initial symptom onset 1, 2

Approximately 70% of Bell's palsy patients with complete paralysis recover facial function completely within 6 months even without treatment 1
Patients with incomplete paralysis have higher recovery rates, up to 94% 1
Most patients begin showing signs of recovery within 2-3 weeks of symptom onset 1
Antiviral therapy alone should not be prescribed as it is ineffective 3, 2

Children have better prognosis with higher rates of spontaneous recovery than adults 3, 1
For pregnant women, treatment should be individualized with careful assessment of benefits and risks 5

Starting steroid treatment beyond the 72-hour window provides minimal benefit and exposes patients to medication risks 1, 2
Failing to provide adequate eye protection for patients with impaired eye closure can lead to corneal damage 5, 1
Not referring patients with incomplete recovery after 3 months for specialist evaluation 1